Petmed Express CFO Sells $20,250 in Stock (PETS)
Petmed Express (NASDAQ:PETS) CFO Bruce S. Rosenbloom unloaded 1,500 shares of the company’s stock on the open market in a transaction dated Thursday, June 12th. The stock was sold at an average price of $13.50, for a total value of $20,250.00. Following the transaction, the chief financial officer now directly owns 41,184 shares of the company’s stock, valued at approximately $555,984. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Shares of Petmed Express (NASDAQ:PETS) opened at 13.31 on Tuesday. Petmed Express has a 52-week low of $12.13 and a 52-week high of $17.75. The stock has a 50-day moving average of $13.24 and a 200-day moving average of $13.92. The company has a market cap of $265.7 million and a price-to-earnings ratio of 14.78.
Petmed Express (NASDAQ:PETS) last posted its quarterly earnings results on Monday, May 5th. The company reported $0.23 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.22 by $0.01. The company had revenue of $48.60 million for the quarter, compared to the consensus estimate of $55.02 million. During the same quarter last year, the company posted $0.23 earnings per share. Petmed Express’s revenue was down 4.9% compared to the same quarter last year. Analysts expect that Petmed Express will post $0.92 EPS for the current fiscal year.
A number of research firms have recently commented on PETS. Analysts at Zacks reiterated a “neutral” rating on shares of Petmed Express in a research note on Friday, May 23rd. They now have a $14.00 price target on the stock. Analysts at Northcoast Research downgraded shares of Petmed Express from a “buy” rating to a “neutral” rating in a research note on Thursday, May 1st.
PetMed Express, Inc (NASDAQ:PETS) and its subsidiaries, doing business as 1-800-PetMeds, is a pet pharmacy.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.